APA

Link J. O., Taylor J. G., Trejo-Martin A., Kato D., Katana A. A., Krygowski E. S., Yang Z., Zipfel S., Cottell J. J., Bacon E. M., Tran C. V., Yang C. Y., Wang Y., Wang K. W., Zhao G., Cheng G., Tian Y., Gong R., Lee Y., Yu M., Gorman E., Mogalian E. & Perry J. K. (20200922). Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi. : Bioorganic & medicinal chemistry letters.

Chicago

Link John O, Taylor James G, Trejo-Martin Alejandra, Kato Darryl, Katana Ashley A, Krygowski Evan S, Yang Zheng-Yu, Zipfel Sheila, Cottell Jeromy J, Bacon Elizabeth M, Tran Chinh V, Yang Cheng Y, Wang Yujin, Wang Kelly W, Zhao Guangyu, Cheng Guofeng, Tian Yang, Gong Ruoyu, Lee Yu-Jen, Yu Mei, Gorman Eric, Mogalian Erik and Perry Jason K. 20200922. Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi. : Bioorganic & medicinal chemistry letters.

Harvard

Link J. O., Taylor J. G., Trejo-Martin A., Kato D., Katana A. A., Krygowski E. S., Yang Z., Zipfel S., Cottell J. J., Bacon E. M., Tran C. V., Yang C. Y., Wang Y., Wang K. W., Zhao G., Cheng G., Tian Y., Gong R., Lee Y., Yu M., Gorman E., Mogalian E. and Perry J. K. (20200922). Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi. : Bioorganic & medicinal chemistry letters.

MLA

Link John O, Taylor James G, Trejo-Martin Alejandra, Kato Darryl, Katana Ashley A, Krygowski Evan S, Yang Zheng-Yu, Zipfel Sheila, Cottell Jeromy J, Bacon Elizabeth M, Tran Chinh V, Yang Cheng Y, Wang Yujin, Wang Kelly W, Zhao Guangyu, Cheng Guofeng, Tian Yang, Gong Ruoyu, Lee Yu-Jen, Yu Mei, Gorman Eric, Mogalian Erik and Perry Jason K. Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi. : Bioorganic & medicinal chemistry letters. 20200922.